How Five UChicago Innovators Are Fighting the IP Gender Gap

It is estimated that only 16.2% of inventors named in international patent applications were women in 2022, according to data from the World Intellectual Property Organization (WIPO). In an analysis…

University of Chicago Joins Global Scholars Program

The University of Chicago has joined the competitive program which is supported by the Novartis Institutes for BioMedical Research (NIBR) and designed to provide researchers with funding as well as…

Esya Labs Supports Drug Discovery Efforts at Novartis: ‘This is Only the Beginning,’ says CEO

Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first companies to use its technology. Novartis, a global healthcare company, has…

Esya Labs Leads Paradigm Shift in Alzheimer’s Using Novel Biomarkers and AI for Revolutionary 360° Perspective of Disease

Esya Labs is developing tools for the early, precise, and cost-effective detection of neurodegenerative diseases to support drug discovery and personalized medicine efforts. In her lab at the University…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept